These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 1974498

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Disposition of carvedilol enantiomers in patients with liver cirrhosis: evidence for disappearance of stereoselective first-pass extraction.
    Neugebauer G, Gabor M, Reiff K.
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S142-6. PubMed ID: 1378143
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of the pharmacokinetic properties of bisoprolol and carvedilol in healthy dogs.
    Beddies G, Fox PR, Papich MD, Kanikanti VR, Krebber R, Keene BW.
    Am J Vet Res; 2008 Dec; 69(12):1659-63. PubMed ID: 19046015
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of carvedilol after intravenous and oral administration in conscious healthy dogs.
    Arsenault WG, Boothe DM, Gordon SG, Miller MW, Chalkley JR, Petrikovics I.
    Am J Vet Res; 2005 Dec; 66(12):2172-6. PubMed ID: 16379664
    [Abstract] [Full Text] [Related]

  • 13. The pharmacokinetics of carvedilol and its metabolites after single and multiple dose oral administration in patients with hypertension and renal insufficiency.
    Gehr TW, Tenero DM, Boyle DA, Qian Y, Sica DA, Shusterman NH.
    Eur J Clin Pharmacol; 1999 Jun; 55(4):269-77. PubMed ID: 10424319
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Enantioselective pharmacokinetics of carvedilol in human volunteers.
    Phuong NT, Lee BJ, Choi JK, Kang JS, Kwon KI.
    Arch Pharm Res; 2004 Sep; 27(9):973-7. PubMed ID: 15473670
    [Abstract] [Full Text] [Related]

  • 17. Stereoselective effect of amiodarone on the pharmacokinetics of racemic carvedilol.
    Fukumoto K, Kobayashi T, Komamura K, Kamakura S, Kitakaze M, Ueno K.
    Drug Metab Pharmacokinet; 2005 Dec; 20(6):423-7. PubMed ID: 16415527
    [Abstract] [Full Text] [Related]

  • 18. A new molecule with vasodilating and beta-adrenoceptor blocking properties.
    Abshagen U.
    J Cardiovasc Pharmacol; 1987 Dec; 10 Suppl 11():S23-32. PubMed ID: 2454364
    [Abstract] [Full Text] [Related]

  • 19. Stereoselective metabolism of carvedilol in the rat. Use of enantiomerically radiolabeled pseudoracemates.
    Fujimaki M, Shintani S, Hakusui H.
    Drug Metab Dispos; 1991 Dec; 19(4):749-53. PubMed ID: 1680650
    [Abstract] [Full Text] [Related]

  • 20. Chiral analysis of carvedilol and its metabolites hydroxyphenyl carvedilol and O-desmethyl carvedilol in human plasma by liquid chromatography-tandem mass spectrometry: Application to a clinical pharmacokinetic study.
    Nardotto GHB, Coelho EB, Marques MP, Lanchote VL.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar 15; 1015-1016():173-180. PubMed ID: 26927877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.